OTRKQ

Ontrak, Inc.

OTC · Services-Misc Health & Allied Services, NEC · Inc. DE · CIK 0001136174
$0.00010000 0.00%
Vol
Inst. Holders3 funds
Inst. Value$251.00
Inst. Activity0 buys / 1 sells
Exchange OTC·Sector Services-Misc Health & Allied Services, NEC·Inc. DE·CIK 0001136174·Prev Close $0.00010000

Recent Activity

Inst.
UBS Group AG — TRIM
10 shares ($5.00)
Inst.
CITADEL ADVISORS LLC — NEW
19,210 shares ($27.9K)

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Jul 2025
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 9, 2025 Roth Capital MAINTAIN Buy → Buy

Top Institutional Holders

FundValueMove
MORGAN STANLEY$236.00
BANK OF AMERICA CORP$10.00
UBS Group AG$5.00TRIM
3 institutional holders with $251.00 total value (503 shares) as of 2025-Q2. Top holders: MORGAN, BANK, UBS. Net selling activity: 1 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q2

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY473$236.0094.0%
2BANK OF AMERICA CORP /DE/20$10.004.0%
3UBS Group AG10$5.002.0%TRIM -44.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGTRIM1810-44.4%$5.002025-Q2
CITADEL ADVISORS LLCNEW19,210$27.9K2025-Q1
UBS Group AGNEAR_EXIT1,63017-99.0%$30.002024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jul 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2025-06-30
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 9, 2025 Roth Capital MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Dec 1, 20252410086%
Nov 1, 20252410086%
Oct 1, 20252410086%
Sep 1, 20252410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.